Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Starving Out Malaria Parasites

17.03.2006


New class of selective inhibitors paralyze essential plasmodium enzymes



The most dangerous variant of the malaria parasite, Plasmodium falciparum, infects up to 600 million people every year. The search for new effective therapies is thus an urgent area of research. An international team headed by François Diederich has now found a new point of attack: using a novel class of inhibitors, the researchers aim to block certain plasmodium enzymes known as plasmepsins, “starving out” the malaria parasite.

Plasmepsins belong to the family of aspartic protease enzymes. They dismantle human hemoglobin to deliver the amino acids that plasmodia need in order to grow. In developing a new inhibitor, it is important to ensure that it blocks all of the plasmodium plasmepsins while remaining inactive toward human aspartic proteases.


The team of researchers from the Swiss Federal Institute of Technology (ETH) in Zurich, the University of Victoria (Canada), Washington University, St. Louis (USA), and Actelion Pharmaceuticals in Allschwil (Switzerland) started with the previously determined spatial structure of one of the plasmepsins, plasmepsin II. This enzyme has a sort of pocket, formed by the opening of a peptide loop, which seemed to be a suitable point of attack for an inhibitor. On the basis of computer simulations, the researchers successfully developed a family of molecules that fit well into this cavity. The central structural element of these molecules is a bicyclic diamine framework: a six-membered ring of carbon atoms in which two opposite carbon atoms are additionally bridged by the nitrogen of the amino group. A second amino group is bound to a neighboring carbon atom. Like a pincer, the diamine framework clamps onto the catalytic dyad (the two catalytically active aspartate groups) of the plasmepsin. An additional side group fits into a second, adjacent pocket (S1/S3-cavity) of the enzyme.

Enzymatic assays pointed the way to the most effective molecules. It was demonstrated that these did not only block plasmepsin II, for which they were specifically tailored: plasmodium plasmepsins I and IV were both even more strongly inhibited. These enzymes clearly have a very similar structure. In contrast, human aspartyl proteases seem to have a completely different spatial structure because they are not affected at all. In cell cultures of plasmodium-infected red blood cells, the new inhibitors were able to inhibit the growth of the parasites. “We are now trying to further improve the activity of the inhibitors,” says Diederich, “with the goal of developing a new class of antimalaria agents.”

François Diederich | Angewandte Chemie
Further information:
http://www.diederich.chem.ethz.ch/
http://pressroom.angewandte.org

More articles from Life Sciences:

nachricht Cancer diagnosis: no more needles?
25.05.2018 | Christian-Albrechts-Universität zu Kiel

nachricht Less is more? Gene switch for healthy aging found
25.05.2018 | Leibniz-Institut für Alternsforschung - Fritz-Lipmann-Institut e.V. (FLI)

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Powerful IT security for the car of the future – research alliance develops new approaches

The more electronics steer, accelerate and brake cars, the more important it is to protect them against cyber-attacks. That is why 15 partners from industry and academia will work together over the next three years on new approaches to IT security in self-driving cars. The joint project goes by the name Security For Connected, Autonomous Cars (SecForCARs) and has funding of €7.2 million from the German Federal Ministry of Education and Research. Infineon is leading the project.

Vehicles already offer diverse communication interfaces and more and more automated functions, such as distance and lane-keeping assist systems. At the same...

Im Focus: Molecular switch will facilitate the development of pioneering electro-optical devices

A research team led by physicists at the Technical University of Munich (TUM) has developed molecular nanoswitches that can be toggled between two structurally different states using an applied voltage. They can serve as the basis for a pioneering class of devices that could replace silicon-based components with organic molecules.

The development of new electronic technologies drives the incessant reduction of functional component sizes. In the context of an international collaborative...

Im Focus: LZH showcases laser material processing of tomorrow at the LASYS 2018

At the LASYS 2018, from June 5th to 7th, the Laser Zentrum Hannover e.V. (LZH) will be showcasing processes for the laser material processing of tomorrow in hall 4 at stand 4E75. With blown bomb shells the LZH will present first results of a research project on civil security.

At this year's LASYS, the LZH will exhibit light-based processes such as cutting, welding, ablation and structuring as well as additive manufacturing for...

Im Focus: Self-illuminating pixels for a new display generation

There are videos on the internet that can make one marvel at technology. For example, a smartphone is casually bent around the arm or a thin-film display is rolled in all directions and with almost every diameter. From the user's point of view, this looks fantastic. From a professional point of view, however, the question arises: Is that already possible?

At Display Week 2018, scientists from the Fraunhofer Institute for Applied Polymer Research IAP will be demonstrating today’s technological possibilities and...

Im Focus: Explanation for puzzling quantum oscillations has been found

So-called quantum many-body scars allow quantum systems to stay out of equilibrium much longer, explaining experiment | Study published in Nature Physics

Recently, researchers from Harvard and MIT succeeded in trapping a record 53 atoms and individually controlling their quantum state, realizing what is called a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

In focus: Climate adapted plants

25.05.2018 | Event News

Save the date: Forum European Neuroscience – 07-11 July 2018 in Berlin, Germany

02.05.2018 | Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

 
Latest News

In focus: Climate adapted plants

25.05.2018 | Event News

Flow probes from the 3D printer

25.05.2018 | Machine Engineering

Less is more? Gene switch for healthy aging found

25.05.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>